Emulate Garners $12,000,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7d00184-1a76-469c-af37-0b325dfcb37b
Date
7/29/2014
Company Name
Emulate
Mailing Address
Undisclosed Cambridge, MA 02138 USA
Company Description
Emulate launches to commercialize automated human Organs-on-Chips platform to accelerate drug development, detect toxicities and advance personalized medicine.
Website
http://www.emulatebio.com
Transaction Type
Venture Equity
Transaction Amount
$12,000,000
Transaction Round
Series A
Proceeds Purposes
Emulate will use the proceeds from the financing to advance the first commercial applications of its automated Organs-on-Chips platform through co-innovation with corporate and clinical clients, and through internal development programs.
M&A Terms
Venture Investor
Venture Investor
Venture Investor